IMVT
Price
$27.35
Change
+$1.17 (+4.47%)
Updated
Jan 14 closing price
Capitalization
5.51B
34 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$23.81
Change
+$0.37 (+1.58%)
Updated
Jan 14 closing price
Capitalization
16.56B
32 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs ROIV

Header iconIMVT vs ROIV Comparison
Open Charts IMVT vs ROIVBanner chart's image
Immunovant
Price$27.35
Change+$1.17 (+4.47%)
Volume$1.81M
Capitalization5.51B
Roivant Sciences
Price$23.81
Change+$0.37 (+1.58%)
Volume$5.81M
Capitalization16.56B
IMVT vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
IMVT vs. ROIV commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (IMVT: $27.35 vs. ROIV: $23.81)
Brand notoriety: IMVT and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 107% vs. ROIV: 77%
Market capitalization -- IMVT: $5.51B vs. ROIV: $16.56B
IMVT [@Biotechnology] is valued at $5.51B. ROIV’s [@Biotechnology] market capitalization is $16.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • IMVT’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IMVT and ROIV are a good buy in the short-term.

Price Growth

IMVT (@Biotechnology) experienced а +2.32% price change this week, while ROIV (@Biotechnology) price change was +8.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

IMVT is expected to report earnings on Feb 18, 2026.

ROIV is expected to report earnings on Feb 16, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($16.6B) has a higher market cap than IMVT($5.51B). ROIV YTD gains are higher at: 9.723 vs. IMVT (7.592). IMVT has higher annual earnings (EBITDA): -486.69M vs. ROIV (-1.14B). ROIV has more cash in the bank: 4.39B vs. IMVT (522M). IMVT has less debt than ROIV: IMVT (98K) vs ROIV (98.8M). ROIV has higher revenues than IMVT: ROIV (20.3M) vs IMVT (0).
IMVTROIVIMVT / ROIV
Capitalization5.51B16.6B33%
EBITDA-486.69M-1.14B43%
Gain YTD7.5929.72378%
P/E RatioN/A1.97-
Revenue020.3M-
Total Cash522M4.39B12%
Total Debt98K98.8M0%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMVTROIV
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
70%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 17 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IMVT
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGLYX11.700.08
+0.69%
Brookfield Global Listed InfrastructureI
CMJAX44.810.07
+0.16%
Calvert US Mid Cap Core Rspnb Idx A
FSFWX76.750.04
+0.05%
American Funds SMALLCAP World 529-F-3
BARAX88.76-0.20
-0.22%
Baron Asset Retail
GSEUX68.47-0.52
-0.75%
Goldman Sachs US Equity Insights R6

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+4.47%
ROIV - IMVT
61%
Loosely correlated
+1.58%
IDYA - IMVT
52%
Loosely correlated
+5.53%
CLDX - IMVT
50%
Loosely correlated
+1.58%
XENE - IMVT
50%
Loosely correlated
+3.02%
NUVL - IMVT
50%
Loosely correlated
+6.59%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.58%
IMVT - ROIV
61%
Loosely correlated
+4.47%
IDYA - ROIV
47%
Loosely correlated
+5.53%
CRNX - ROIV
47%
Loosely correlated
+2.04%
VIR - ROIV
46%
Loosely correlated
+8.08%
CLDX - ROIV
46%
Loosely correlated
+1.58%
More